The significance of prognosis factors in oncology
Nagel, G.A.; Schuff-Werner, P.
Der Internist 22(3): 150-155
1981
ISSN/ISBN: 0020-9554 PMID: 7012080 Document Number: 178868
Document emailed within 1 workday
Related Documents
Zaino, R.J. 1995: Pathologic indicators of prognosis in endometrial adenocarcinoma. Selected aspects emphasizing the GOG experience. Gynecologic Oncology Group Pathology Annual 30: 1-28Gutiérrez, J.L.; Val-Bernal, J.F.; Portillo, J.A.; Garijo, F.; Buelta, L. 1990: Prognosis factors in adenocarcinoma of the kidney. I. Staging, clinical and macroscopic factors of the tumor Archivos Espanoles de Urologia 43(5): 481-486
Hetzel, H.; Bichler, A.; Fuchs, D.; Hausen, A.; Reibnegger, G.; Wachter, H. 1983: Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer Cancer Detection and Prevention 6(1-2): 263-266
Ganguly, S.; Roy, A. 2012: Predictive factors in oncology Journal of the Indian Medical Association 110(2): 76-77
Sgambato, A.; Flamini, G.; Cittadini, A. 1996: New prognostic factors in oncology Rays 21(4): 559-572
Maisch, B.; Schuff-Werner, P.; Berg, P.A.; Kochsiek, K. 1979: Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. the significance of serum inhibition and rosette inhibitory factors Clinical and Experimental Immunology 38(2): 198-203
Blay, J.Y. 2000: Use of hematopoietic growth factors in oncology Presse Medicale 29(36): 1984-1986
Steffen, R.; Genton, C.Y. 1980: The significance of lymphocytic infiltration for the prognosis in dysgerminomas Schweizerische Medizinische Wochenschrift 110(26): 1013-1019
Glaspy, J.A. 2003: Hematopoietic management in oncology practice. Part 2. Erythropoietic factors Oncology 17(12): 1724-1730; Discussion: 1731-1732 1735, 1739
Sánchez Durán, A. 1988: Methodology for the study of prognostic factors in oncology. I. Actuarial analysis Medicina Clinica 90(4): 166-169
Blay, J.Y.; Le Cesne, A.; Blanc-Vincent, M.P.; Fervers, B.; Latour, J.F.; Philip, T. 2000: Standards, options, and recommendations for the use of hematopoietic growth factors in oncology Presse Medicale 29(36): 2004-2008
Pescia, R.; Heinzel, F. 1978: Parasternal lymphoscintigraphy in mastocarcinoma, its diagnostic value and significance for prognosis Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 31(6): 337-341
Hardmeier, T. 1970: Malignant melanoma: histological findings and their significance for prognosis Schweizerische Medizinische Wochenschrift 100(23): 967-971
Karthaus, M.; Ganser, A. 1996: Current status of the clinical application of hematopoietic growth factors in oncology Therapeutische Umschau. Revue Therapeutique 53(11): 863-873
Reibnegger, G.; Hetzel, H.; Fuchs, D.; Fuith, L.C.; Hausen, A.; Werner, E.R.; Wachter, H. 1987: Clinical significance of neopterin for prognosis and follow-up in ovarian cancer Cancer Research 47(18): 4977-4981
Ratzmann, K.P.; Raskovic, M.; Thoelke, H. 1992: Significance of proteinuria and hypertension in the prognosis of Type Ii diabetes mellitus Zeitschrift für Arztliche Fortbildung 86(1-2): 31-36
Campbell, R.W. 1979: The incidence, significance and prognosis of arrhythmias in acute myocardial infarction Herz 4(6): 445-451
Mathew, S.; Erozan, Y.S. 1997: Significance of peritoneal washings in gynecologic oncology. The experience with 901 intraoperative washings at an academic medical center Archives of Pathology and Laboratory Medicine 121(6): 604-606
Lewandowski, G.; O'Toole, R.V.; Delgado, G.; Boutselis, J.G. 1989: Carcinoma of the vulva. Significance of surgical margin involvement in assessing prognosis Journal of Reproductive Medicine 34(11): 884-886
Marshall, M. 1989: Social medicine significance, costs, course, therapy and prognosis of venous diseases Versicherungsmedizin 41(3): 89-97